RE: Here v NYCT10 Oct 2020 19:20
I hold SNG and AVCT. I've did hold NCYT and ODX but quite frankly, I don't believe in their products so I've taken profits and moved on. Antibody and lab testing isn't going to get us out of trouble.
I sold out too early on the last SNG rise. It started to drop back from around a quid, so having more than doubled my money I bailed out. It then proceeded to rise again and carried on way beyond two pounds. That was an error, but never mind. Can't complain. I've recently bought back in, think it was around 150 I paid as it was very oversold and will surely re-rate when news lands.
Rapid tests to siginificantly reduce the spread and a highly effective treatment for the few people who do end up in hospital... that's a winning combination.
I bought in here at 40p several months ago and have a very large number of shares. I still believe the biggest rise is yet to come.
Whilst we are on the subject of cross ramping, I've recently taken a large position in BIDS. Much like with Avacta, I think I've got in early on that one before the masses arrive. Shameless plug, sorry.